IPO registrations (S-1, F-1) · Registrants
EMULATE THERAPEUTICS, INC.
- SEC CIK
- 1254348 · filings on EDGAR ↗
- Former names
- Nativis, Inc. (2010–2018); WAVBANK INC (2003–2004)
- Registration
- Form S-1, first filed 2022-08-16, last 2023-09-29; 1 initial registration, 6 amendments
- Outcome
- Withdrawal requested 2024-07-31
- Industry (SIC)
- Surgical & Medical Instruments & Apparatus 3841
- Incorporated in
- WA
- Business address
- 425 PONTIUS AVENUE NORTH, SUITE 200, Seattle, WA 98109
- EIN
- 91-2174500
- EDGAR entity type
- other
Offering terms
- Proposed price range
- $4.00–$6.00 per share (S-1/A filed 2023-09-29)
- Shares offered
- 2,300,000
- Listing
- Nasdaq under the symbol EMTX
- Lead underwriters
- The Benchmark Company
- Syndicate
- of Contents; Glossary of Certain Terms; Brookline Capital Markets
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- Form 5500 plan sponsor: NATIVIS, INC. EXACT (EIN (EXACT))
- Form D issuer: EMULATE THERAPEUTICS, INC. EXACT (CIK (EXACT))
- Lobbying client: EMULATE THERAPEUTICS Fuzzy (name and state)
Filings 8
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2022-08-16 | S-1 | S-1 (registration) | EMULATE THERAPEUTICS, INC. | 0001493152-22-023239 ↗ |
| 2022-09-27 | S-1/A | S-1/A (amendment) | EMULATE THERAPEUTICS, INC. | 0001493152-22-026927 ↗ |
| 2023-01-04 | S-1/A | S-1/A (amendment) | EMULATE THERAPEUTICS, INC. | 0001493152-23-000347 ↗ |
| 2023-01-26 | S-1/A | S-1/A (amendment) | EMULATE THERAPEUTICS, INC. | 0001493152-23-002618 ↗ |
| 2023-07-10 | S-1/A | S-1/A (amendment) | EMULATE THERAPEUTICS, INC. | 0001493152-23-024057 ↗ |
| 2023-09-06 | S-1/A | S-1/A (amendment) | EMULATE THERAPEUTICS, INC. | 0001493152-23-031864 ↗ |
| 2023-09-29 | S-1/A | S-1/A (amendment) | EMULATE THERAPEUTICS, INC. | 0001493152-23-034850 ↗ |
| 2024-07-31 | RW | RW (withdrawal request) | EMULATE THERAPEUTICS, INC. | 0001493152-24-029670 ↗ |
Prospectus pages read 1
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2023-09-29 | S-1/A | registration statement | $4.00–$6.00 | $5.00 | 2,300,000 | $11,500,000 | Nasdaq EMTX | 4 | primary document; range, price sentence, shares headline, proceeds computed, cover names 4 | document ↗ |
Private offerings before or after (Form D)
| First filed | Issuer | Industry | Offering | Sold | Investors | Filings |
|---|---|---|---|---|---|---|
| 2019-09-20 | EMULATE THERAPEUTICS, INC. | Biotechnology | $5,000,000 | $450,000 | 2 | 1 |
| 2017-11-20 | Nativis, Inc. | Biotechnology | $10,000,000 | $4,117,760 | 33 | 2 |
| 2017-05-19 | Nativis, Inc. | Biotechnology | $5,000,000 | $210,000 | 5 | 1 |
| 2015-12-24 | Nativis, Inc. | Biotechnology | $50,000,000 | $9,618,795 | 49 | 2 |
| 2015-06-23 | Nativis, Inc. | Biotechnology | $10,000,000 | $725,000 | 4 | 1 |
| 2014-02-10 | Nativis, Inc. | Biotechnology | $18,000,000 | $11,480,715 | 39 | 2 |
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| Form D issuer | EMULATE THERAPEUTICS, INC. | WA | Form D private offerings | CIK (EXACT) |
| Lobbying client | EMULATE THERAPEUTICS | WA | Federal lobbying (LDA) | name and state |
| Patent assignee | EMulate Therapeutics, Inc. | WA | Patents (USPTO) | name and state |
| Trademark owner | EMulate Therapeutics, Inc. | WA | Trademarks (USPTO) | name and state |
| Form 5500 plan sponsor | NATIVIS, INC. | EIN (EXACT) |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.
Others with the same interests
SIC industry Surgical & Medical Instruments & Apparatus, WA first:
- SONOSITE INC WA
- QUINTON CARDIOLOGY SYSTEMS INC WA
- VIVOS INC WA
- Avalon Holding Group, Inc. WA
- OSR Health, Inc. WA
- KESTRA MEDICAL TECHNOLOGIES, LTD. WA
- MIV THERAPEUTICS INC A1
- BIOCUREX INC A1
- Enox Biopharma Inc A1
- Stimcell Energetics Inc. A1
In other datasets, the same topic (Technology) in WA:
- Form D issuer: 2nd Watch, Inc. (Form D private offerings)
- Lobbying client: 4G AMERICAS (F/K/A 3G AMERICAS LLC) (Federal lobbying (LDA))
Interests: Surgical & Medical Instruments & Apparatus · Technology